ResMed Revenue And Earnings Rise As Company Returns Over $1 Billion To Shareholders
RMD: $35.51 +0.37% · MC: $48.0B
ResMed’s first-quarter revenue rose 6% to approximately $1.4 billion, while diluted earnings per share increased 23% and non-GAAP diluted earnings per share rose 14% year on year. The company returned over $1 billion to shareholders through buybacks and dividends, and declared a quarterly dividend; it also said conversions between its US and Australian registers will be paused during the relevant dividend record-date period. A director’s earlier share sale was made under a pre-arranged trading plan.

Comments